We engineered BT20 and MDA-MB-468 (human EGFR+ breast cancer cell lines) cells with control shRNA (targeted to firefly luciferase) or shRNA targeted to HUNK (HUNK shRNA1 and shRNA2) (Fig. 2a and Supplementary Fig. 2a). This evidence concerns the gene EGFR and breast cancer.